At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 32 enrolled
Drug / intervention
Honey Mouthwash +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy of Thyme Honey Mouth Rinse on Polypharmacy-induced Xerostomia (A Randomized Controlled Clinical Trial With a Biochemical Assessment)
In Brief
A Phase 4 clinical trial evaluating Honey Mouthwash and Normal saline for Xerostomia. Completed, enrolled 32 participants across 1 site.
Detailed Summary
The study is designed to evaluate the clinical efficacy of thyme honey as a mouth rinse in the management of polypharmacy-induced xerostomia concerning the unstimulated whole salivary flow rate and quality of life of patients along with a biochemical assessment of salivary nitric oxide levels.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsXerostomia
CountriesEgypt
Collaborators--
Timeline
Phase 4CompletedFinished
202420252026
First PostedJan 2024
Enrollment StartJan 2024
Primary CompletionNov 2024
Study CompletionDec 2024
TodayJul 2026
First PostedJan 11, 2024
Enrollment StartJan 15, 2024
Primary CompletionNov 2, 2024
Study CompletionDec 2, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.5 years ago
Interventions
Honey Mouthwashdrug
0.2% thyme honey mouth rinse
Normal salinedrug
0.9% sodium chloride